Lateritin
CAS No. 65454-13-9
Lateritin ( Bassiatin )
Catalog No. M27818 CAS No. 65454-13-9
Lateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 578 | Get Quote |
|
10MG | 822 | Get Quote |
|
25MG | 1233 | Get Quote |
|
50MG | 1665 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLateritin
-
NoteResearch use only, not for human use.
-
Brief DescriptionLateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
-
DescriptionLateritin is An Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor and a platelet aggregation inhibitor from the mycelial cake of Gibberella lateritium. Bassiatin is the (3S,6R) isomer.
-
SynonymsBassiatin
-
PathwayOthers
-
TargetOther Targets
-
RecptorElastase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65454-13-9
-
Formula Weight261.3
-
Molecular FormulaC15H19NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)C1OC(=O)C(Cc2ccccc2)N(C)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hildreth, J.E.K. N-D-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry. Biochem. J. 207(2), 363-366 (1982).
molnova catalog
related products
-
HAEGTFTSDVSSYLE
HAEGTFTSDVSSYLE is a polypeptide from patent CN 102920658 B. GLP-I analog contains the sequence.
-
P300/CBP-IN-3
P300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.
-
Alisporivir intermed...
Alisporivir intermediate-1 is an intermediate in the synthesis of Alisporivir and is used for the treatment of inflammatory and viral diseases.